FIELD: biotechnology; immunology.
SUBSTANCE: invention relates to monoclonal antibodies against IL-31. Also the compositions containing monoclonal antibodies against IL-31, as well as nucleic acids, vectors, and host cells for producing such antibodies are disclosed.
EFFECT: invention provides novel anti-IL-31 antibodies for the prevention and treatment of IL-31 mediated disorders in mammalian veterinary medicine, in particular for safe and effective alternative treatments for atopic and allergic dermatoses in cats and horses.
29 cl, 26 dwg, 2 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE VACCINES AGAINST INTERLEUKIN-31 | 2019 |
|
RU2786441C2 |
| ANTI-IL31 ANTIBODIES FOR VETERINARY USE | 2018 |
|
RU2795485C2 |
| ANTIBODY FOR SPECIFIC BINDING WITH INTERLEUKIN 4 RECEPTOR | 2017 |
|
RU2774446C2 |
| ANTIBODY AGAINST IL-5, ITS ANTIGEN-BINDING FRAGMENT AND ITS MEDICAL USE | 2018 |
|
RU2772716C2 |
| ANTIBODY AGAINST HUMAN INTERLEUKIN-4 ALPHA RECEPTOR, METHOD OF ITS PREPARATION AND ITS APPLICATION | 2021 |
|
RU2807060C1 |
| ANTIBODY BINDING HUMAN IL-4R, ANTIGEN-BINDING FRAGMENT THEREOF, AND MEDICAL APPLICATION THEREOF | 2019 |
|
RU2779649C1 |
| METHODS OF TREATING PATHOLOGICAL CONDITIONS WITH ANTIBODIES WHICH BIND TO THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R) | 2013 |
|
RU2718751C2 |
| ANTI-IL-5 ANTIBODIES | 2017 |
|
RU2758008C2 |
| ANTIBODIES CONTAINING POLYPEPTIDE INTEGRATED INTO FRAME REGION 3 | 2019 |
|
RU2796254C2 |
| HUMAN TSLP ANTIBODIES AND USE THEREOF | 2021 |
|
RU2825460C1 |
